| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
LifeStance Health Gr (NASDAQ:LFST) reported its Q4 earnings results on Wednesday, February 28, 2024 at 06:00 AM.
Here's what investors need to know about the announcement.
LifeStance Health Gr missed estimated earnings by -33.0%, reporting an EPS of $-0.12 versus an estimate of $-0.09.
Revenue was up $51.24 million from the same period last year.
Last quarter the company missed on EPS by $0.09 which was followed by a 3.0% drop in the share price the next day.
Here's a look at LifeStance Health Gr's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.09 | -0.11 | -0.13 |
| EPS Actual | -0.17 | -0.13 | -0.09 | -0.13 |
| Revenue Estimate | 255.16M | 255.15M | 246.43M | 216.61M |
| Revenue Actual | 262.89M | 259.58M | 252.59M | 229.36M |
To track all earnings releases for LifeStance Health Gr visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LFST
